Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Apple
AAPL
|
+$814M |
| 3 |
NVIDIA
NVDA
|
+$700M |
| 4 |
Broadcom
AVGO
|
+$647M |
| 5 |
Shopify
SHOP
|
+$593M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$701M |
| 2 |
Johnson & Johnson
JNJ
|
+$685M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$484M |
| 4 |
Meta Platforms (Facebook)
META
|
+$407M |
| 5 |
HubSpot
HUBS
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.47% |
| 2 | Financials | 12.85% |
| 3 | Industrials | 11.86% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Stereotaxis
STXS
$144M
| $55.1K | ﹤0.01% |
25,971
-54
| -0.2% | -$110 |
|
3652
Rimini Street
RMNI
$465M
| $55K | ﹤0.01% |
14,602
-447
| -3% | -$1.49K |
|
3653
Riskified
RSKD
$713M
| $54.6K | ﹤0.01% |
10,939
-55
| -0.5% | -$263 |
|
3654
DiaMedica Therapeutics
DMAC
$360M
| $54.2K | ﹤0.01% |
+13,885
| New | +$54.1K |
|
|
NINE
3655
DELISTED
Nine Energy Service
NINE
| $53.7K | ﹤0.01% |
69,614
-39,788
| -36% | -$29.2K |
|
|
VXRT
3656
DELISTED
Vaxart
VXRT
| $53.7K | ﹤0.01% |
118,706
-27,660
| -19% | -$12K |
|
3657
HF Foods Group
HFFG
$82.9M
| $51.1K | ﹤0.01% |
16,070
+4,351
| +37% | +$16.6K |
|
|
AIRJ
3658
Montana Technologies Corp
AIRJ
$419M
| $50.4K | ﹤0.01% |
+10,877
| New | +$50K |
|
|
ILLR
3659
Triller Group Inc
ILLR
$19.8M
| $48.5K | ﹤0.01% |
+5,216
| New | +$46K |
|
3660
Denison Mines
DNN
$2.93B
| $48.5K | ﹤0.01% |
26,631
+88
| +0.3% | +$133 |
|
3661
Design Therapeutics
DSGN
$886M
| $48.4K | ﹤0.01% |
14,364
+3,033
| +27% | +$11.3K |
|
|
QVCGA
3662
DELISTED
QVC Group Inc Series A
QVCGA
| $46.6K | ﹤0.01% |
16,963
-9,950
| -37% | -$57.2K |
|
3663
Montauk Renewables
MNTK
$249M
| $46.1K | ﹤0.01% |
20,777
-18,948
| -48% | -$40.1K |
|
3664
DHI Group
DHX
$162M
| $45.3K | ﹤0.01% |
+15,266
| New | +$29.5K |
|
3665
Siebert Financial
SIEB
$68.4M
| $45.1K | ﹤0.01% |
+10,212
| New | +$41.5K |
|
3666
Larimar Therapeutics
LRMR
$434M
| $43.9K | ﹤0.01% |
15,204
-908
| -6% | -$2.1K |
|
3667
Ocugen
OCGN
$437M
| $43.4K | ﹤0.01% |
44,752
-143,926
| -76% | -$119K |
|
3668
Spero Therapeutics
SPRO
$72.4M
| $43.4K | ﹤0.01% |
+14,968
| New | +$21.5K |
|
3669
Tilly's
TLYS
$131M
| $41.8K | ﹤0.01% |
30,289
-23,292
| -43% | -$32K |
|
3670
Lucid Diagnostics
LUCD
$181M
| $41K | ﹤0.01% |
+35,617
| New | +$46K |
|
3671
Arbe Robotics
ARBE
$89.6M
| $40.5K | ﹤0.01% |
+22,760
| New | +$32.5K |
|
3672
Myomo
MYO
$55.5M
| $37K | ﹤0.01% |
+17,113
| New | +$62K |
|
3673
Traeger
COOK
$170M
| $36.7K | ﹤0.01% |
430
+115
| +37% | +$8.84K |
|
|
MAPS
3674
DELISTED
WM TECHNOLOGY INC A
MAPS
| $35.6K | ﹤0.01% |
39,708
-61
| -0.2% | -$66 |
|
3675
AtaiBeckley Inc
ATAI
$2.68B
| $35.5K | ﹤0.01% |
+16,198
| New | +$29K |
|
Similar funds
Invesco's Q2 2025 Portfolio in Review
As of Q2 2025, Invesco held 3,922 positions worth $588B, up 11% from $528B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Invesco's Q2 2025 filing shows 165 new, 1,670 increased, 1,835 reduced and 165 closed positions. Its largest new stake was QXO Inc: 27,561,664 shares worth $594M. The largest sale was UnitedHealth, an estimated $701M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q2 2025 buy was QXO Inc: 27,561,664 shares worth $594M.
- Invesco added most to Microsoft in Q2 2025, an estimated $1.45B increase.
- Invesco's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $701M.
- Invesco fully exited Discover Financial Services in Q2 2025, selling an estimated $484M.
- Invesco's ten largest holdings make up 20% of its $588B portfolio in Q2 2025.
- Invesco opened 165 new positions and closed 165 in Q2 2025.
- Invesco's portfolio value rose 11% quarter-over-quarter to $588B.
Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.